2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow TD-9855: new trials by email Literature Review of TD-9855 trials Research Report on TD-9855
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) TD-9855, Placebo - Neurogenic Orthostatic Hypotension, Multiple System Atrophy (MSA) With Orthostatic Hypotension | Phase 2 | Completed | Theravance Biopharma | 34 | 2017-09-09 | 2022-09-26 |
| A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) TD-9855, Placebo - Attention-Deficit/Hyperactivity Disorder, ADHD | Phase 2 | Completed | Theravance Biopharma | 295 | 2011-12-01 | 2022-04-04 |
Attention Deficit Disorder with Hyperactivity (1) · Hypotension, Orthostatic (1) · Multiple System Atrophy (1) · Multiple system atrophy (MSA) with orthostatic hypotension (1) · Parkinson Disease (1) · Pure Autonomic Failure (1)
United States (2)